Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats

Diabetes

Volumn 55, Issue 5, 2006, Pages 1470-1477

  Nakae, Mika ^a   Kamiya, Hideki ^a   Naruse, Keiko ^a   Horio, Naoichi ^b   Ito, Yasuki ^a   Mizubayashi, Ryuichi ^a   Hamada, Yoji ^a   Nakashima, Eitaro ^a   Akiyama, Noboru ^a   Kobayashi, Yasuko ^a   Watarai, Atsuko ^a   Kimura, Nachi ^a   Horiguchi, Masayuki ^b   Tabata, Yasuhiko ^c   Oiso, Yutaka ^a   Nakamura, Jiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

bFGF, basic fibroblast growth factor; CGH, cross linked gelatin hydrogel; HGF, hepatocyte growth factor; MCT, mean circulation time; MNCV, motor nerve conduction velocity; NBF, nerve blood flow; NGF, nerve growth factor; RBF, retinal blood flow

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; SODIUM CHLORIDE; THIOCTIC ACID; ANGIOGENIC FACTOR; CROSS LINKING REAGENT; FIBROBLAST GROWTH FACTOR 2; GELATIN; GELATIN POLYGLUTAMIC ACID GLUE; GELATIN-POLYGLUTAMIC ACID GLUE; POLYGLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BODY WEIGHT; CONTROLLED STUDY; CROSS LINKING; DIABETIC NEUROPATHY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYDROGEL; HYPOALGESIA; MALE; MECHANICAL STIMULATION; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RAT; RETINA BLOOD FLOW; SCIATIC NERVE; SOLEUS MUSCLE; STREPTOZOCIN DIABETES; THIGH; TIBIAL NERVE; ANIMAL; BLOOD FLOW VELOCITY; DRUG COMBINATION; EXPERIMENTAL DIABETES MELLITUS; INTRAMUSCULAR DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RETINA BLOOD VESSEL; WISTAR RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOOD FLOW VELOCITY; CROSS-LINKING REAGENTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DRUG COMBINATIONS; FIBROBLAST GROWTH FACTOR 2; GELATIN; INJECTIONS, INTRAMUSCULAR; MALE; NEURAL CONDUCTION; POLYGLUTAMIC ACID; RATS; RATS, WISTAR; RETINAL VESSELS;

EID: 33745298315     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db05-1160     Document Type: Article

References (49)

1. Vinik AI, Park TS, Stansberry KB, Pittenger GL: Diabetic neuropathies. Diabetologia 43:957-973, 2000
2. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of lomg-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Tomlinson DR, Willars GB, Carrington AL: Aldose reductase inhibitors and diabetic complications. Pharmacol Ther 54:151-194, 1992
4. Yagihashi S, Kamijo M, Ido Y, Mirrless DJ: Effect of long-term aldose reductase inhibition in development of experimental diabetic neuropathy: ultrastructural and morphometric studies of sural nerve in streptozotocin- induced diabetic rats. Diabetes 39:690-696, 1990
5. Yagihashi S, Kamijo M, Baba M, Yagihashi N, Nagai K: Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41:47-52, 1992
6. Nakamura J, Kato K, Hamada Y, Nakayama M, Chaya S, Nakashima E, Naruse K, Kasuya Y, Mizubayashi R, Miwa K, Yasuda Y, Kamiya H, Ienaga K, Sakakibara F, Koh N, Hotta N: A protein kinase C-β-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 48:2090-2095, 1999
7. Vincent AM, Russell JW, Low P, Feldman EL: Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25:612-628, 2004
8. Cameron NE, Cotter MA: Neurovascular dysfunction in diabetic rats: potential contribution of autooxidation and free radicals examined using transition metal chelating agents. J Clin Invest 96:1159-1163, 1995
9. Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerrild KA, Gospodarowicz D, Fiddes JC: Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233:545-548, 1986
10. Schweigerer L, Neufeld G, Mergia A, Abraham JA, Fiddes JC, Gospodarowicz D: Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc Natl Acad Sci U S A 84:842-846, 1987
11. Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R: Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci U S A 82:6507-6511, 1985
12. Yang HT, Yan Z, Abraham JA, Terjung RL: VEGF121- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production. Am J Physiol Heart Circ Physiol 280:H1097-H1104, 2001
13. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G: Hypotensive activity of fibroblast growth factor. Science 254:1208-1210, 1991
14. Shaw R, Cianchetti R, Pleasure D, Kreider B: Basic fibroblast growth factor prevents cAMP-induced apoptosis in cultured Schwann cells. J Neurosci Res 47:400-404, 1997
15. Iwai-Kanai E, Hasegawa K, Fujita M, Araki M, Yanazume T, Adachi S, Sasayama S: Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J Cell Physiol 190:54-62, 2002
16. Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V, Le Bourhis X: FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev 11:295-302, 2000
17. Tanaka E, Ase K, Okuda T, Okumura M, Nogimori K: Mechanism of acceleration of wound healing by basic fibroblast growth factor in genetically diabetic mice. Biol Pharm Bull 19:1141-1148, 1996
18. Kawaguchi H, Kurokawa T, Hanada K, Hiyama Y, Tamura M, Ogata E, Matsumoto T: Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135:774-781, 1994
19. Nakamura T, Hanada K, Tamura M, Shibanushi T, Nigi H, Tagawa M, Fukumoto S, Matsumoto T: Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136:1276-1284, 1995
20. Stark J, Baffour R, Garb JL, Kaufman J, Berman J, Rhee S, Norris MA, Friedmann P: Basic fibroblast growth factor stimulates angiogenesis in the hindlimb of hyperglycemic rats. J Surg Res 79:8-12, 1998
21. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P: Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16:181-191, 1992
22. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA: Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105:788-793, 2002
23. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H: Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401-1403, 1992
24. Yuge T, Furukawa A, Nakamura K, Nagashima Y, Shinozaki K, Nakamura T, Kimura R: Metabolism of the intravenously administered recombinant human basic fibroblast growth factor, trafermin, in liver and kidney: degradation implicated in its selective localization to the fenestrated type microvasculatures. Biol Pharm Bull 20:786-793, 1997
25. Tabata Y, Nagano A, Ikada Y: Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5:127-138, 1999
26. Tabata Y, Ikada Y: Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20:2169-2175, 1999
27. Abe K, Saito H: Effects of basic fibroblast growth factor on central nervous system functions. Pharmacol Res 43:307-312, 2001
28. Katsuki H, Itsukaichi Y, Matsuki N: Distinct signaling pathways involved in multiple effects of basic fibroblast growth factor on cultured rat hippocampal neurons. Brain Res 885:240-250, 2000
29. Grothe C, Nikkhah G: The role of basic fibroblast growth factor in peripheral nerve regeneration. Anat Embryol 204:171-177, 2001
30. Fujimoto E, Mizoguchi A, Hanada K, Yajima M, Ide C: Basic fibroblast growth factor promotes extension of regenerating axons of peripheral nerve: in vivo experiments using a Schwann cell basal lamina tube model. J Neurocytol 26:511-528, 1997
31. Kawaguchi H, Nakamura K, Tabata Y, Ikada Y, Aoyama I, Anzai J, Nakamura T, Hiyama Y, Tamura M: Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 86:875-880, 2001
32. Naruse K, Hamada Y, Nakashima E, Kato K, Mizubayashi R, Kamiya H, Yuzawa Y, Matsuo S, Murohara T, Matsubara T, Oiso Y, Nakamura J: Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 54:1823-1828, 2005
33. Koshu K, Kamiyama K, Oka N, Endo S, Takaku A, Saito T: Measurement of regional blood flow using hydrogen gas generated by electrolysis. Stroke 13:483-487, 1982
34. Abiko T, Abiko A, Clermont AC, Shoelson B, Horio N, Takahashi J, Adamis AP, King GL, Bursell SE: Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 52:829-837, 2003
35. Horio N, Clermont AC, Abiko A, Abiko T, Shoelson BD, Bursell SE, Feener EP: Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats. Diabetologia 47:113-123, 2004
36. Takagi C, King GL, Clermont AC, Cummins DR, Takagi H, Bursell SE: Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an alpha-glucosidase inhibitor. Curr Eye Res 14:741-749, 1995
37. Calcutt NA, Freshwater JD, Mizisin AP: Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47:718-724, 2004
38. Kostyk SK, Kourembanas S, Wheeler EL, Medeiros D, McQuillan LP, D'Amore PA, Braunhut SJ: Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells. Am J Physiol 269: H1583-H1589, 1995
39. Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ: Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 51:2227-2232, 2002
40. Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, Silver M, Krainin JG, Weinberg DH, Ropper AH, Isner JM: Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 107:1083-1092, 2001
41. Kato N, Nemoto K, Nakanishi K, Morishita R, Kaneda Y, Uenoyama M, Ikeda T, Fujikawa K: Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats. Diabetes 54:846-854, 2005
42. Apfel SC: Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol 50:393-413, 2002
43. Pittenger G, Vinik A: Nerve growth factor and diabetic neuropathy. Exp Diabesity Res 4:271-285, 2003[Medline]
44. Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M, Sugimachi K, Sueishi K: Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 90:966-973, 2002
45. Onimaru M, Yonemitsu Y, Tanii M, Nakagawa K, Masaki I, Okano S, Ishibashi H, Shirasuna K, Hasegawa M, Sueishi K: Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs. Circ Res 91:923-930, 2002
46. Tsutsumi N, Yonemitsu Y, Shikada Y, Onimaru M, Tanii M, Okano S, Kaneko K, Hasegawa M, Hashizume M, Maehara Y, Sueishi K: Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis. Circ Res 94:1186-1194, 2004
47. Sasaki T, Hatta H, Osawa G: Cytokines and podocyte injury: the mechanism of fibroblast growth factor 2-induced podocyte injury. Nephrol Dial Transplant 14 (Suppl. 1):33-34, 1999
48. Sasaki T, Jyo Y, Tanda N, Tamai H, Osawa G: The role of basic fibroblast growth factor (FGF2) in glomerular epithelial cell injury. Contrib Nephrol 118:68-77, 1996
49. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952-2962, 1993